Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   155,668    

Indirect Shares

   6,673      
Direct Value   $5,148,031    

Indirect Value

   $0      
Total Shares   162,341      
Total Value   $5,148,031      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $921,621 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $921,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2023-06-02 40,493 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    180         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-04-28 4 A $70.30 $10,897 D/D 155 26,826 0 -
CVTX CV Therapeutics Inc Senior Vice President and CFO   •       –      –    2004-12-16 4 OE $9.00 $67,500 D/D 7,500 27,488 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-06-05 4 AS $122.30 $201,669 D/D (1,649) 28,229 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-11-16 4 AS $104.30 $2,085,918 D/D (20,000) 28,229 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-10-31 5 A $51.26 $11,022 D/D 215 28,444 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2009-02-25 4 OE $15.58 $194,734 D/D 12,499 29,075 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-06-04 4 D $120.46 $216,948 D/D (1,801) 29,878 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-02-24 4 A $0.00 $0 D/D 12,247 30,347 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-02-28 4 AS $94.00 $2,820,000 D/D (30,000) 30,347 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-03-25 4 B $1.63 $16,271 D/D 10,000 30,644 2.39 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-06-01 4 AS $124.16 $489,811 D/D (3,945) 31,679 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2012-05-29 4 A $0.00 $0 D/D 33,000 33,000 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-05-01 4 S $64.42 $1,803,897 D/D (28,000) 33,000 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2022-06-06 4 AS $19.25 $123,673 D/D (6,424) 33,980 0 %
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-29 4 AS $126.15 $199,065 D/D (1,578) 35,624 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2020-12-04 4 A $0.00 $0 D/D 15,889 36,451 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2014-06-07 4 D $3.06 $6,255 D/D (2,044) 36,827 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-29 4 D $125.57 $540,579 D/D (4,305) 37,202 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-07-01 4 AS $59.56 $243,063 D/D (4,066) 37,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-09-04 4 AS $69.00 $621,000 D/D (9,000) 37,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-12-02 4 AS $70.14 $631,273 D/D (9,000) 37,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-10-31 5 A $55.44 $4,047 D/D 73 38,023 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2014-03-11 4 D $3.65 $17,659 D/D (4,838) 38,871 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2022-06-02 4 A $0.00 $0 D/D 17,275 40,404 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2023-06-02 4 AS $23.01 $198,760 D/D (8,638) 40,493 0 %
  180  Records found
  1   2   3   4  5   6   7   8      
  Page 4 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us